Skip to content

Comparing the effects of ozone and platelet-rich plasma (PRP) treatment in patients with lateral epicondylitis disorder

Comparing the effects of ozone therapy and PRP therapy in patients with lateral epicondylitis disorder

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241211064021N9
Enrollment
60
Registered
2025-10-06
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparing the effects of ozone and platelet-rich plasma (PRP) treatment in patients with lateral epicondylitis disorder. Lateral epicondylitis, unspecified elbow

Interventions

Intervention 1: Intervention group: Platelet-Rich Plasma (PRP) Treatment: This group underwent platelet-rich plasma injection. The preparation and injection procedure is as follows: Sampling: 10 ml of

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of lateral epicondylitis tennis elbow according to clinical criteria by a specialist physician Minimum pain intensity according to VAS>3

Exclusion criteria

Exclusion criteria: Simultaneous occurrence of other wrist diseases such as advanced osteoarthritis, infection, etc. Simultaneous occurrence of other wrist diseases such as advanced osteoarthritis, infection, etc.

Design outcomes

Primary

MeasureTime frame
Assessing changes in pain intensity at the wrist. Timepoint: At baseline, week 4, and week 12 (after completion of the study). Method of measurement: Visual Analogue Pain Scale (VAS): A ruler with a rating of 0 (no pain) to 10 (the most severe pain).

Secondary

MeasureTime frame
Evaluation of patients' quality of life. Timepoint: At baseline, week 4, and week 12 (after completion of the study). Method of measurement: Standardized SF-12 questionnaire: Scores range from 0 (worst quality of life) to 100 (best quality of life).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNikta Nikbakht

Hamedan University of Medical Sciences

drnikbakhtnikta@gmail.com+98 81 3131 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026